ClinicalTrials.gg
Active, not recruitingNCT07322705Updated Nov 3, 2026

Can Perineal Post-Free Traction in Hip Arthroscopy Effectively Reduce Perineal Complications?

An interventional study of Perineal Post-Free Traction and Perineal Post Traction in Femoroacetabular Impingement Syndrome, sponsored by ChunBao Li. Active, not recruiting at 10 sites in China. Open to participants aged 15 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by ChunBao Li · Not applicable, Interventional, and Treatment

Updated Nov 3, 2026Now Active, not recruitingGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
270
Allocation
Randomized
Ages
15 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 11 studies in Femoracetabular Impingement with a site in China — 1 open to participants now, 2 under way, none of them phase 3. Femoracetabular Impingement · China.

Started
2026
with 1 other
No phase
2 of 11
1 open now
Registered
9th of 11
by date
Lead sponsor
2 of 11
ChunBao Li

Among the 11 studies in Femoracetabular Impingement with a site in China, this one is one of 2 that started in 2026, is one of 2 with no phase, and was the 9th registered.

Femoracetabular Impingement

116 studies on the registry are indexed under Femoracetabular Impingement; 37 are open to participants now.

Browse Femoracetabular Impingement studies →

Open to participants now

1 of the 11 studies in Femoracetabular Impingement with a site in China is open now. Recruiting first, the newest first:

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 19 Femoracetabular Impingement studies recruiting now, 6 (32%) set no upper age limit and 11 (58%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.

This study: 15 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Femoracetabular Impingement with a site in China, or all of them as a file.
02

Study summary

The goal of this clinical trial is to analyze the impact of perineal post-free traction versus traditional perineal post traction on perineal complications in hip arthroscopy. The main question it aims to answer is:

  • Can Perineal Post-Free Traction in Hip Arthroscopy Effectively Reduce Perineal Complications? Researchers will compare the perineal-post-free traction group with the conventional perineal-post traction group to see if the former decreases perineal complications and improves efficiency without compromising surgical outcomes.

Participants will:

  • Undergo either perineal-post-free or standard perineal-post traction during hip arthroscopy
  • Complete nerve-injury checks on day 1 and at discharge, and hip-function questionnaires (VAS, mHHS, IHOT-12, HOS) at 3 months
  • Allow collection of operating times, hospital stay, and direct medical costs for economic analysis
03

Conditions studied

  • Femoroacetabular Impingement Syndrome
04

Who can participate

Ages eligible
15 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 15 to 60 years;
  • Met the diagnostic criteria of femoroacetabular impingement syndrome (FAI) and indicated for hip arthroscopy based on patient history, symptoms, signs, physical examination, imaging (pelvic anteroposterior view, frog-leg view, CT 3D reconstruction, MRI), and diagnostic injections;
  • Able to read and sign the form.

Exclusion criteria

Exclusion Criteria:

  • History of high-energy hip trauma, previous ipsilateral or contralateral hip surgery, avascular necrosis of the femoral head, slipped capital femoral epiphysis, Perthes disease, severe osteoporosis, tumors, acetabular stress fractures, or proliferative or immune hip diseases;
  • Diseases causing groin numbness, foot numbness, sexual dysfunction, urinary dysfunction, skin injuries, perineal injuries, nerve injuries, radicular pain, inner or outer thigh numbness;
  • Abnormal heart, lung, liver, kidney function, severe coagulation disorders, poorly controlled diabetes, judged by the researcher to have an infection risk;
  • Consciousness disorders, psychiatric disorders, or neuromuscular dysfunction affecting lower limb function;
  • Active infection foci (systemic or local infectious lesions);
  • Pregnancy, lactation, or planned pregnancy during the clinical study period;
  • Participation in another clinical trial within the past 3 months;
  • Patients deemed unsuitable for the clinical trial by the researcher for other reasons.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
270 participants (estimated)

Study arms

  • Experimental
    Perineal Post-Free Traction

    Procedure: Perineal Post-Free Traction

  • Active comparator
    Perineal Post Traction

    Procedure: Perineal Post Traction

Interventions

  • ProcedurePerineal Post-Free Traction

    Traction achieved with a thoraco-abdominal belt and contralateral groin strap; operating table tilted 10-15° Trendelenburg under fluoroscopy to 8-10 mm joint space. No perineal post is used, eliminating direct perineal pressure.

  • ProcedurePerineal Post Traction

    Standard traction table with padded perineal post placed against the groin providing counter-traction; affected limb distracted under fluoroscopy to 8-10 mm joint space while contralateral limb is abducted.

06

What researchers measure

Primary outcomes

  1. The incidence of perineal nerve injury

    The incidence of perineal nerve injury included: perineal numbness, pain, soft tissue injury, sexual function and urinary dysfunction.

    Time frame: The first day after surgery

Secondary outcomes

  1. The incidence of pain, numbness, soft tissue injury in other places

    Lower limb ankle numbness and soft tissue injury; the contralateral groin pain, numbness and soft tissue injury; chest pain, numbness, soft tissue injury with fixed place

    Time frame: The first day after surgery

  2. Patients at discharge perineum area incidence of nerve injury

    Patients at discharge perineum area incidence of nerve injury include: perineum area numbness, pain, soft tissue injuries, sexual and urinary dysfunction.

    Time frame: 7 days after surgery

  3. Intraoperative traction time

    Intraoperative traction time

    Time frame: During surgery (intraoperatively)

  4. Preoperative preparation time

    Preoperative preparation time

    Time frame: Immediately before surgery (preoperatively)

  5. Operating time

    Operating time

    Time frame: During surgery (intraoperatively)

  6. The average length of hospital stay after surgery

    The average length of hospital stay after surgery

    Time frame: 6 weeks after surgery

  7. Postoperative joint function assessment

    Visual Analog Scale (VAS) (range 0-10; higher scores indicate worse outcomes).

    Time frame: 3 months after surgery

  8. Postoperative joint function assessment

    Modified Harris Hip Score (mHHS) (range 0-100; higher scores indicate better outcomes).

    Time frame: 3 months after surgery

  9. Postoperative joint function assessment

    Hip Outcome Score (HOS) (range 0%-100%; higher scores indicate better outcomes).

    Time frame: 3 months after surgery

  10. Postoperative joint function assessment

    International Hip Outcome Tool 12-Item Questionnaire (iHOT-12), range 0-100, higher scores mean better hip function

    Time frame: 3 months after surgery

  11. Economic Evaluation - Pain Intensity

    This study will conduct an economic evaluation from a healthcare sector and societal perspective. Pain intensity is assessed using the Visual Analog Scale (VAS), a unidimensional measure reported as scores on a 0-100 mm scale. Effectiveness analysis will incorporate this clinical outcome. Safety will be evaluated by monitoring the incidence of adverse events within 3 months postoperatively.

    Time frame: 14 days after surgery

  12. Economic Evaluation - Hip Function

    This study will conduct an economic evaluation from a healthcare sector and societal perspective. Hip function is assessed using the modified Harris Hip Score (mHHS), a measure specifically for hip dysfunction and related symptoms, reported as scores on a 0-100 scale. Effectiveness analysis will incorporate this clinical outcome. Safety will be evaluated by monitoring the incidence of adverse events within 3 months postoperatively.

    Time frame: 14 days after surgery

  13. Mean Total Healthcare Cost per Patient within 14 Days Postoperatively

    This is the cost input measure for the economic evaluation, adopting a healthcare system perspective. All direct medical costs related to the surgery and subsequent care from the day of surgery until 14 days postoperatively will be collected via the Hospital Information System. Costs include fees for surgery, anesthesia, medical supplies, hospitalization, medication, imaging and laboratory tests, and additional costs for managing complications. The mean total cost per patient (in Chinese Yuan, CNY) will be calculated separately for the "conventional perineal-post traction group" and the "perineal-post-free traction group".

    Time frame: Data collection period: From randomization until 14 days postoperatively.

07

Study locations

10 sites
08

References and documents

Publications

  • Wang L, Zhang L, Wang Y, Wang M, Zheng L, Zhang J, Wu Y, Liu Y, Jiang L, Kang X, Li C. Multicentre randomised controlled trial protocol in China comparing postless hip arthroscopy with conventional perineal post-assisted hip arthroscopy to reduce perineal complications in patients undergoing hip arthroscopy for femoroacetabular impingement: the POSTLESS-HIP trial. BMJ Open. 2026 Sep 28;16(9):e118402. doi: 10.1136/bmjopen-2026-118402. PubMed 42805650 ↗

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared with external independent researchers. The original informed consent only permits internal study team, institutional ethics committee and regulatory authorities to access coded data for trial quality control, without explicit participant consent for sharing de-identified IPD for external secondary research. Full trial protocol, statistical analysis plan and analytic codes are available to eligible researchers for result replication upon reasonable request.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2026 to primary completion in Sep 2026, 6 months.

Of 41 non-industry interventional studies with no phase under Femoracetabular Impingement, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 28 and three quarters within 79. This study's 6 months is below that.

Counting every sponsor, half of 42 studies reached it within 41 months; a quarter within 28 and three quarters within 79.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 17, 2025
First posted
Jan 7, 2026
StartActual
Mar 30, 2026
Primary completionActual
Sep 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Nov 3, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 42805650 ↗
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Recruiting→Active, not recruiting
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 42805650 ↗
    + 4 other changes: verification date, date precision, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07322705
Lead sponsor
ChunBao Li
Responsible party
ChunBao Li (Director of the Department of Sports Medicine, Chinese PLA General Hospital) — Sponsor-investigator
First posted
Jan 7, 2026
Start date
Mar 30, 2026
Primary completion
Sep 30, 2026
Completion
Dec 30, 2026 (estimated)
Last update
Nov 3, 2026

Study contacts

chunbao li, MD
principal investigator · Chinese PLA General Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion